Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gblin M 750mcg/150mg Capsule

Prescription Icon
Prescription Required

Marketer

Alkem Laboratories Ltd

Salt Composition

Methylcobalamin (750mcg) + Pregabalin (150mg)

Overview Gblin M 750mcg/150mg Capsule

Gablin-M 750mcg/150mg capsules are a prescription medication for managing neuropathic pain. It works by regulating calcium channel function within nerve cells, thereby reducing pain signals. This medication also safeguards nerve fibers and promotes the repair of damaged nerve cells. Gablin-M 750mcg/150mg capsules are administered orally, with or without food, ideally before sleep. Consistent daily timing helps maintain stable drug levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Common side effects include upper respiratory infection, increased appetite, elevated mood, shaking, visual blurring, dry mouth, lightheadedness, and drowsiness. Avoid driving or mentally demanding tasks until the medication's effects are understood. Side effects are generally mild and subside over time. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor immediately. Disclose all other medications you're using, as interactions may reduce Gablin-M's efficacy or alter its action. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Gblin M 750mcg/150mg Capsule

Managing neuropathic pain

Major Benefits of Gblin M 750mcg/150mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gblin M 750mcg/150mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.

Common Side effects of Gblin M 750mcg/150mg Capsule:

  • Sleepiness
  • Dizziness
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Increased appetite
  • Blurred vision
  • Constipation
  • Muscle cramp
  • Edema (swelling)
  • Erectile dysfunction
  • Weight gain
  • Balance disorder (loss of balance)
  • Lethargy
  • Vertigo
  • Vomiting
  • Headache
  • Confusion
  • Disorientation
  • Abnormality of voluntary movements

How to use Gblin M 750mcg/150mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. The Gblin M 750mcg/150mg Capsule can be ingested with or without food, although consistent timing is recommended.

How Gblin M 750mcg/150mg Capsule works:

Each Gblin M 750mcg/150mg capsule unites methylcobalamin (a vitamin B variant) and pregabalin. Methylcobalamin aids myelin production, shielding nerve fibers and promoting nerve cell repair. Pregabalin, an alpha-2-delta ligand, manages nerve cell calcium channel activity to reduce pain signaling. This dual action targets and alleviates neuropathic pain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol concurrently with Gblin M 750mcg/150mg Capsules can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gblin M 750mcg/150mg Capsule during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible dangers prior to any prescription. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gblin M 750mcg/150mg Capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Gblin M 750mcg/150mg Capsules might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Gblin M 750mcg/150mg Capsules. Dosage modification may be necessary; physician consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Gblin M 750mcg/150mg Capsules in patients with liver disease is likely safe. Current evidence indicates dose modification may be unnecessary, but physician consultation is advised.

What if you forget to take Gblin M 750mcg/150mg Capsule :

Should you forget a Gblin M 750mcg/150mg Capsule dose, administer it immediately. If your next scheduled dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Never take more than the prescribed amount.

Facts to Know About Gblin M 750mcg/150mg Capsule

LabelValue
Addictive None.
Medication Classification Central and Peripheral Nervous System

FAQs on Gblin M 750mcg/150mg Capsule

Each Gblin M 750mcg/150mg capsule contains pregabalin and methylcobalamin. This combined medication is indicated for neuropathic pain management. Its mechanism involves modulating overactive or injured nerves within the central nervous system to reduce pain perception and promote nerve repair.
Discontinuing Gblin M 750mcg/150mg Capsules, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may induce withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual reduction in Gblin M 750mcg/150mg Capsule usage is recommended prior to complete discontinuation.
Taking Gblin M 750mcg/150mg Capsules may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging meal portions. Limit high-calorie foods like sugary drinks, fried items, crisps, pastries, and confectionery. Between meals, opt for fruits, vegetables, and low-calorie snacks instead of junk food. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may help avoid weight increase.
Using Gblin M 750mcg/150mg Capsules can cause drowsiness, potentially leading to unexpected sleep onset during routine tasks. This sleepiness may occur without prior warning signs. Therefore, refrain from driving, operating equipment, working at heights, or engaging in risky activities, especially when initiating treatment, until the medication's effects are understood. Report any such sleep episodes to your physician.
Severe adverse reactions to Gblin M 750mcg/150mg Capsules are infrequent. Nevertheless, serious side effects such as allergic reactions, suicidal ideation, or limb edema (hands, feet, or legs) can occur. Discontinue Gblin M 750mcg/150mg Capsules and seek immediate medical attention if any of these serious side effects appear. Allergic reactions manifest as facial, oral, lip, gum, tongue, or neck swelling; respiratory distress; skin rashes; urticaria (raised welts); or blisters. Monitor for any significant alterations, particularly abrupt shifts in mood, behavior, cognition, or affect, or the emergence of suicidal thoughts.
Patients may observe initial improvements with Gblin M 750mcg/150mg Capsules within two weeks of starting treatment. Complete therapeutic effects, however, might require two to three months or longer in certain individuals.
Should you miss a scheduled dose of Gblin M 750mcg/150mg Capsule, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If it's not nearly time for the next dose, take the medication immediately upon remembering, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one, as this can heighten the chance of adverse reactions. For any uncertainty regarding missed doses, seek guidance from your physician.
Increasing the prescribed dosage won't necessarily improve results; it could instead heighten the risk of severe adverse reactions and toxicity. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Avoid consuming alcohol during treatment with Gblin M 750mcg/150mg Capsules. Alcohol may intensify the sedative effects of this medication.
Regular monitoring by your physician may be necessary following initiation of Gblin M 750mcg/150mg Capsule therapy. Consult your doctor immediately if your symptoms fail to improve with the prescribed dosage of Gblin M 750mcg/150mg Capsules, or if you experience adverse effects that interfere with your daily life.
Retain the medication within its original packaging until administration. Maintain storage in a cool, dry environment. Keep the medication out of the view and reach of children. Dispose of any surplus medicine using a designated method to prevent accidental ingestion by children, pets, or others.
Gblin M 750mcg/150mg Caps...
122
MRP 149
18% off